Brussels Regulatory Conference Organized in partnership between ECCA & ECPA

Speakers in red are confirmed

Crop Protection

European Regulatory Conference

15th-16th March 2017

Hotel Le Plaza

Boulevard Adolphe Max 118

B-1000 Brussels

Organized in partnership between ECCA & ECPA

Day 1: Wednesday 15th March
Conference workshops
Workshop 1 (10h15 – 11h30)
Market & communications / Workshop 2 (09h20 – 11h30)
Regulatory issues
Registration
09h15: Introduction
Chairman: tbc / 09h15: Introduction
Chairman: Hans Mattaar, ECCA
09h20: ECPA EEG speaker tbc – Environmental risk assessment challenges / 09h20: Ingrid Langer, AGES - Harmonized dose expression in 3D crops and other efficacy challenges
09h40: Beth Hall, Syngenta - Industry view: Key efficacy challenges in zonal system
10h00: Q&A / 10h00: Q&A
10h10: Matthew Phillips, PhillipsMcDougall - Market update / 10h10: Chris Dobe, Syngenta - Update on co-formulants
10h30: David Cary, IBMA - Low risk substances: An opportunity?
10h45 Graeme Taylor, ECPA – Benefits campaign
10h50: Jeroen Meeussen, Minor Use Coordination Facility - Minor use developments
11h15: Panel discussion / 11h10: Panel discussion
11h30 / Coffee
Introductory session
Chairman: Hans Mattaar, ECCA
11h50 / Jean-Philippe Azoulay, ECPA Director General: Welcome address
12h00 / Wolfgang Reinert - Update on implementation of Regulation 1107/2009
12h30 / Martyn Griffiths, Bayer - Regulation 1107/2009 - challenges for today and the future
12h55 / Dara O'Shea, DG SANTE – Evaluating the implementation of Regulation 1107/2009
13h20 / Question and answer
13h30 / Lunch
Product evaluation challenges
14h30 / Darren Flynn, CRD - Zonal system and (inter)zonal cooperation
14h50 / Chrstian Prohaska, AGES - Article 43 - where's the silver bullet?
15h15 / J-L Alonso-Prados, INIA - South zone challenges
15h40 / Jeanne Roederer, Adama - Industry view on key challenges in product authorisation
16h00 / Panel discussion
16h30 / Coffee
Active substance evaluation update
17h00 / Mark Williams, DG SANTE - AS review programme
17h25 / Benedicte Vagenende, EFSA - EFSA update on active substances review
17h50 / Luuk van Duijn, Ctgb - MS challenges in AS review - can we improve?
18h15 / Panel discussion
18h30 / Cocktail reception
19h15 / Evening debate
20h00 / Conference dinner
Day 2: Thursday 16th March
Developments in human health risk assessment
08h20 / Welcome
08h30 / Dick Lewis, Syngenta or Ivana Fegert, BASF - Regulatory challenges in human health RA
08h55 / Roland Solecki, BfR - Member State view on challenges in human health RA
09h20 / Kiki Machera, Benaki Phytopathological Institute – Impact on active substance conclusions on product re-registration
09h45 / Troy Seidle, HSi - Opportunities for efficient testing strategies
10h10 / Panel discussion
10h30 / Coffee
Endocrine disruption update
11h00 / Karin Nienstedt, DG SANTE - Endocrine disruption and guidance update
11h25 / José Tarazona, EFSA - ECPA role in developing guidance on endocrine
11h50 / Jean-Pierre Busnardo, DuPont – Industry view on Endocrine disruption
12h10 / Panel discussion
12h30 / Lunch
Legislative review
13h30 / Hans Mattaar, ECCA – Introduction to a discussion on the review of 1107 & 396
13h45 / Canadian Representation speaker - Data call-in system - what can we learn from Canada?
14h10 / Johan Axelman, Sweden - Can we streamline the EU evaluation process for PPPs?
14h35 / Kees Romijn, Bayer – The role of protection goals to support the EU regulatory process
15h00 / Panel discussion
15h20 / Conclusions
15h30 / Close